Interleukin-3 receptors in Hodgkin's disease.
作者信息
Bosshart Herbert
出版信息
Am J Pathol. 2003 Jan;162(1):355-6; author reply 356-7. doi: 10.1016/s0002-9440(10)63827-8.
Abstract
摘要
相似文献
1
Interleukin-3 receptors in Hodgkin's disease.
Am J Pathol. 2003 Jan;162(1):355-6; author reply 356-7. doi: 10.1016/s0002-9440(10)63827-8.
2
The role of interleukin-3 in classical Hodgkin's disease.
Leuk Lymphoma. 2005 Mar;46(3):303-11. doi: 10.1080/10428190400013712.
3
Expression of functional interleukin-3 receptors on Hodgkin and Reed-Sternberg cells.
Am J Pathol. 2002 Feb;160(2):585-96. doi: 10.1016/S0002-9440(10)64878-X.
4
Vimentin expression by Reed-Sternberg cells in Hodgkin's disease.
Virchows Arch A Pathol Anat Histopathol. 1992;421(1):9-11. doi: 10.1007/BF01607132.
5
Suppression of an IL-13 autocrine growth loop in a human Hodgkin/Reed-Sternberg tumor cell line by a novel IL-13 antagonist.
Cell Immunol. 2001 Jul 10;211(1):37-42. doi: 10.1006/cimm.2001.1828.
6
A role for interleukin 13 in Hodgkin's disease.
Mol Med Today. 1999 Nov;5(11):463. doi: 10.1016/s1357-4310(99)01586-5.
7
CD30 expression in L&H cells of Hodgkin's disease, nodular lymphocyte predominant type.
Histopathology. 2003 Apr;42(4):406-7. doi: 10.1046/j.1365-2559.2003.01552_3.x.
8
High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma.
Am J Pathol. 1999 Jun;154(6):1685-91. doi: 10.1016/S0002-9440(10)65424-7.
9
Characterization of NF-kappaB expression in Hodgkin's disease: inhibition of constitutively expressed NF-kappaB results in spontaneous caspase-independent apoptosis in Hodgkin and Reed-Sternberg cells.
Mod Pathol. 2001 Apr;14(4):297-310. doi: 10.1038/modpathol.3880306.
10
CD83 in Hodgkin and Reed-Sternberg cells.
Pathology. 2002 Oct;34(5):479-81. doi: 10.1080/0031302021000009469.
引用本文的文献
1
Belinostat in patients with refractory or relapsed peripheral T-cell lymphoma: a perspective review.
Ther Adv Hematol. 2015 Aug;6(4):202-8. doi: 10.1177/2040620715592567.
本文引用的文献
1
Expression of survival receptors in Hodgkin disease cell lines.
Blood. 2002 May 1;99(9):3484-5; author reply 3485-6. doi: 10.1182/blood-2002-01-0122.
2
Expression of functional interleukin-3 receptors on Hodgkin and Reed-Sternberg cells.
Am J Pathol. 2002 Feb;160(2):585-96. doi: 10.1016/S0002-9440(10)64878-X.
3
Deficient major histocompatibility complex class II antigen presentation in a subset of Hodgkin's disease tumor cells.
Blood. 1998 Oct 1;92(7):2252-9.
4
The origin of Hodgkin and Reed/Sternberg cells in Hodgkin's disease.
Annu Rev Immunol. 1998;16:471-93. doi: 10.1146/annurev.immunol.16.1.471.
5
6
Hematopoietic regulators: redundancy or subtlety?
Blood. 1993 Dec 15;82(12):3515-23.
7
Apoptosis in cancer therapy: crossing the threshold.
Cell. 1994 Aug 26;78(4):539-42. doi: 10.1016/0092-8674(94)90518-5.
8
A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group.
Blood. 1994 Sep 1;84(5):1361-92.
9
Suppression of apoptotic death in hematopoietic cells by signalling through the IL-3/GM-CSF receptors.
EMBO J. 1995 Jan 16;14(2):266-75. doi: 10.1002/j.1460-2075.1995.tb07000.x.
10
Activating point mutations in the common beta subunit of the human GM-CSF, IL-3 and IL-5 receptors suggest the involvement of beta subunit dimerization and cell type-specific molecules in signalling.
EMBO J. 1995 Sep 1;14(17):4276-87. doi: 10.1002/j.1460-2075.1995.tb00102.x.
Zotero 插件